TScan, Novartis to develop T cell receptor therapies for solid tumors
TScan Therapeutics has partnered with Swiss pharma giant Novartis to discover and develop novel TCR-engineered T cell receptor therapies for the treatment of solid tumors using the former’s TScan Discovery Platform. The TScan platform will be used for discovering novel cancer antigens that can be targeted by TCR-based therapies. TScan Therapeutics will be engaged in […]